New portable biosensor could revolutionize heart failure screening at home

FHS
August 19, 2024
12:58 pm

Heart failure is a leading cause of death worldwide and is especially fatal for people who don’t have access to medical facilities. So, a team of researchers aims to bring heart failure screening from the lab to the home.

Protective genetic variant shields Black Americans from kidney disease risk

Many Black Americans who are thought to have a high risk of developing kidney disease possess a protective genetic variant that nullifies the extra risk,

December 13, 2023

Marijuana emergency department visits for children, teens have spiked since the pandemic started: CDC – The Cannabist

Related Articles Marijuana emergency department visits for children, teens and young adults have spiked since the start of the pandemic more than three years ago,

July 22, 2023

J&J seeks label expansion for Tremfya in ulcerative colitis – Pharmaceutical Technology

Share this article J&J’s Tremfya is forecast to generate $6.5bn in sales in 2030, according to GlobalData. Credit: Michael Vi via Shutterstock. Johnson & Johnson

March 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.